ELIZABETH ATTIG: Open Payments
NPI 1346585882 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 16 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $263 · 2025 $707
Food & beverage: $617Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $393 |
| GlaxoSmithKline, LLC. | 5 | $103 |
| JAZZ PHARMACEUTICALS INC. | 1 | $90 |
| GENZYME CORPORATION | 2 | $53 |
| United Therapeutics Corporation | 1 | $25 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
Products named: NUCALA, FASENRA, XYWAV, DUPIXENT, Tyvaso, LUMRYZ, PURIFIED CORTROPHIN GEL.
Industry payments across PA — which companies pay providers there.
